Hera Diagnostics

Curated by Signal

Developer of cervical cancer screening device

Life Sciences Technologyhera-diagnostics.com

Overview

Developer of cervical cancer screening device The company has developed a device called InstaPap that is used to diagnose cervical cancer in real-time without the use of any sample. The home-based portable screening device consists of a disposable sleeve is used to screen skin cancer, throat cancer, stomach cancer.

Key facts

Founded: 2020
Headquarters: Mcallen, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

Contact

Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

PinMed
Sensor platform and database services for ECG, Imaging and Hemodynamic data
Life Sciences TechnologyPittsburgh, United States
Belharra
Provider of photoaffinity-based chemoproteomics platform  for drug discovery
Life Sciences TechnologySan Diego, United States
AccuraScience
Specializes in NGS data analysis
Life Sciences TechnologyJohnston, United States

About Hera Diagnostics

What does Hera Diagnostics do?

Developer of cervical cancer screening device The company has developed a device called InstaPap that is used to diagnose cervical cancer in real-time without the use of any sample.

Where is Hera Diagnostics headquartered?

Hera Diagnostics is headquartered in Mcallen, United States.

When was Hera Diagnostics founded?

Hera Diagnostics was founded in 2020.

Which sector is Hera Diagnostics in?

Hera Diagnostics operates in Life Sciences Technology.

Who are Hera Diagnostics's competitors?

Companies similar to Hera Diagnostics include PinMed, Belharra, and AccuraScience.